tiprankstipranks
Relmada Therapeutics Inc (DE:4E2)
NASDAQ:4E2
Germany Market

Relmada Therapeutics (4E2) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
3Neutral
11Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Relmada Therapeutics Inc’s (4E2) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Relmada Therapeutics Inc is a Buy.
Relmada Therapeutics Inc’s (4E2) 20-Day exponential moving average is 5.89, while Relmada Therapeutics Inc’s (4E2) share price is €5.75, making it a Sell.
Relmada Therapeutics Inc’s (4E2) 50-Day exponential moving average is 5.67, while Relmada Therapeutics Inc’s (4E2) share price is €5.75, making it a Sell.

Relmada Therapeutics (4E2) Pivot Points

Jun 05, 2026, 11:13 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.70
5.70
5.70
5.70
5.70
5.70
5.70
Fibonacci
5.70
5.70
5.70
5.70
5.70
5.70
5.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relmada Therapeutics (4E2) Moving Averages

Jun 05, 2026, 11:13 AM
Period
Simple
Exponential
MA5
5.82Sell
5.72Sell
MA10
5.91Sell
5.83Sell
MA20
5.97Sell
5.89Sell
MA50
5.89Sell
5.67Sell
MA100
4.82Buy
4.99Buy
MA200
3.57Buy
3.69Buy
Relmada Therapeutics Inc’s (4E2) 10-Day exponential moving average is 5.83, while Relmada Therapeutics Inc’s (4E2) share price is €5.75, making it a Sell.
Relmada Therapeutics Inc’s (4E2) 100-Day exponential moving average is 4.99, while Relmada Therapeutics Inc’s (4E2) share price is €5.75, making it a Buy.
Relmada Therapeutics Inc’s (4E2) stock price is €5.75 and Relmada Therapeutics Inc’s (4E2) 50-day simple moving average is 5.89, creating a Sell signal.
Relmada Therapeutics Inc’s (4E2) stock price is €5.75 and Relmada Therapeutics Inc’s (4E2) 100-day simple moving average is 4.82, creating a Buy signal.
Relmada Therapeutics Inc’s (4E2) stock price is €5.75 and Relmada Therapeutics Inc’s (4E2) 200-day simple moving average is 3.57, creating a Buy signal.

Relmada Therapeutics (4E2) Technical Indicators

Jun 05, 2026, 11:13 AM
Name
Value
Implied Action
RSI (14)
38.90
Neutral
STOCH (9,6)
25.00
Neutral
STOCHRSI (14)
42.76
Neutral
MACD (12,26)
-0.04
Buy
ADX (14)
14.14
Buy
Williams %R
-83.33
Buy
CCI (14)
-212.12
Buy
ATR (14)
0.19
-
Ultimate Oscillator
22.73
Sell
ROC
-14.40
Sell
Relmada Therapeutics Inc’s (4E2) Relative Strength Index (RSI) is 38.90, creating a Neutral signal.
Relmada Therapeutics Inc’s (4E2) Trend Strength Indicator (ADX) is 14.14, creating a Buy signal.
Relmada Therapeutics Inc’s (4E2) Commodity Channel Index (CCI) is -212.12, creating a Buy signal.
Relmada Therapeutics Inc’s (4E2) Price Rate of Change (ROC) is -14.40, creating a Sell signal.

FAQ

Is 4E2 a Buy, Hold, or Sell?
Based on 4E2’s technical indicators, 4E2 is a Sell.
    What is 4E2’s RSI (14)?
    4E2’s RSI (14) is 38.90, which suggests 4E2 is a Neutral.
      What is 4E2’s MACD?
      4E2’s MACD is -0.04, which suggests 4E2 is a Buy.
        What is 4E2’s 5-day moving average?
        4E2’s 5-day moving average is 5.82, which suggests 4E2 is a Sell.
          What is 4E2’s 20-day moving average?
          4E2 20-day moving average is 5.97, which suggests 4E2 is a Sell.
            What is 4E2’s 50-day moving average?
            4E2’s 50-day moving average is 5.89, which suggests 4E2 is a Sell.
              What is 4E2’s 200-day moving average?
              4E2’s 200-day moving average is 3.57, which suggests 4E2 is a Buy.
                What is 4E2’s Williams % R (14)?
                4E2’s Williams % R (14) is -83.33, which suggests 4E2 is a Buy.
                  What is 4E2’s CCI (14)?
                  4E2’s CCI (14) is -212.12, which suggests 4E2 is a Buy.
                    What is the share price of Relmada Therapeutics Inc?